Quickfind
Show latest about:
Sector
Topic
Keep settings
  Freetext search
 Home
 News
 Analysis
 Features
 Market prices
 Technology guide
 Real estate
 Israel in depth
RSS  feeds
  Search results
News
Check-Cap files to raise $15m on Nasdaq
Check-Cap is developing a pill for making an X-ray scan of the intestine.
Gali Weinreb   24 Dec 14   19:07

FDA approves Teva's GRANIX for self-administration
From early 2015 patients will themselves be able to administer the treatment for neutropenia, associated with leukemia.
Globes correspondent    23 Dec 14   15:38

Mapi Pharma again considers Nasdaq IPO
Mapi will now raise $10-30 million in the first quarter of 2015, either through an IPO or a private placement.
Gali Weinreb   23 Dec 14   14:34

Medivation takes up $335m Curetech licensing option
The agreement gives Medivation the license to develop and commercialize Curetech's pidilizumab cancer treatment.
Kobi Yeshayahou   21 Dec 14   14:06

FDA approves Teva allergy spray for children
Globes correspondent    21 Dec 14   11:25

Compugen, Johns Hopkins team on immune markers
Globes correspondent   18 Dec 14   16:13

RedHill boosted by University of Minnesota deal
Globes correspondent   18 Dec 14   14:50

Teva and Russian partner at loggerheads
Shiri Habib-Valdhorn   17 Dec 14   20:47

US court delays Teva launch of generic Celebrex
Globes correspondent   17 Dec 14   12:39

"Copaxone risk dramatically down"
Kobi Yeshayahou   16 Dec 14   18:28

BioLineRX signs Novartis strategic cooperation deal
Gali Weinreb   16 Dec 14   14:56

Another Israeli cannabis co to be traded on Wall Street
Shiri Habib-Valdhorn   15 Dec 14   18:29

Pfizer buys Israel-developed hormone drug from Opko
Gali Weinreb    15 Dec 14   17:11

Pontifax first fund earns 37% return
Gali Weinreb   14 Dec 14   19:09

Features
Good-bye chemotherapy, hello immunotherapy
Compugen CEO Dr. Anat Cohen-Dayag: Today, we dare to talk about curing cancer.
Gali Weinreb   27 Nov 14   11:36

Cancer treatment developer Efranat raises $4.5m
Efranat is conducting human trials of its drug, which uses controversial substance GcMAF.
Gali Weinreb   18 Nov 14   16:13

5 - Consumer Physics: We let you know what you're eating
The company is developing a mobile food scanner that can quantify all food ingredients.
Gali Weinreb   30 Oct 14   20:42

For more results from our archive, Click here.